Bayer Animal Health GmbH and ParaTheraTech, Inc. (PTT), have signed a global license agreement to advance new Cryptosporidiosis treatment options for farm animals. As part of the license agreement, Bayer will develop and commercialize novel compounds based on knowledge and intellectual property licensed by PTT from the University of Washington. Further terms of the agreement have not been disclosed. Photo: Emmy Koeleman One of the biggest unsolved parasite problems
Bayer A
Get full access to all stories on Dairy Global
This Premium article is exclusively available for subscribers
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Get a glimpse into dairy farms worldwide
All the news is brought to you by experienced editors and experts from around the world